105027,1,Admission,O
105027,1,Date,O
105027,1,:,O
105027,1,[,O
105027,1,**2125-9-18**,O
105027,1,],O
105027,1,Discharge,O
105027,1,Date,O
105027,1,:,O
105027,1,[,O
105027,1,**2125-10-8**,O
105027,1,],O
105027,1,Date,O
105027,1,of,O
105027,1,Birth,O
105027,1,:,O
105027,1,[,O
105027,1,**2088-6-30**,O
105027,1,],O
105027,1,Sex,O
105027,1,:,O
105027,1,F,O
105027,1,Service,O
105027,1,:,O
105027,1,MEDICINE,O
105027,1,Allergies,O
105027,1,:,O
105027,1,Sulfa,B-Drug
105027,1,(,I-Drug
105027,1,Sulfonamide,I-Drug
105027,1,Antibiotics,I-Drug
105027,1,),I-Drug
105027,1,/,O
105027,1,Codeine,B-Drug
105027,1,/,O
105027,1,Shellfish,O
105027,1,Derived,O
105027,1,Attending,O
105027,1,:,O
105027,1,[,O
105027,1,**Doctor,O
105027,1,First,O
105027,1,Name,O
105027,1,2080**,O
105027,1,],O
105027,1,Chief,O
105027,1,Complaint,O
105027,1,:,O
105027,1,Thrombocytopenia,O
105027,1,Major,O
105027,1,Surgical,O
105027,1,or,O
105027,1,Invasive,O
105027,1,Procedure,O
105027,1,:,O
105027,1,Right,O
105027,1,IJ,O
105027,1,line,O
105027,1,PICC,O
105027,1,line,O
105027,1,placement,O
105027,1,History,O
105027,1,of,O
105027,1,Present,O
105027,1,Illness,O
105027,1,:,O
105027,1,This,O
105027,1,is,O
105027,1,a,O
105027,1,37,O
105027,1,year,O
105027,1,old,O
105027,1,female,O
105027,1,who,O
105027,1,presented,O
105027,1,to,O
105027,1,OSH,O
105027,1,with,O
105027,1,5,O
105027,1,days,O
105027,1,of,O
105027,1,LLQ/left,O
105027,1,flank,O
105027,1,pain,O
105027,1,.,O
105027,1,She,O
105027,1,was,O
105027,1,initially,O
105027,1,seen,O
105027,1,at,O
105027,1,[,O
105027,1,**Hospital3,O
105027,1,**,O
105027,1,],O
105027,1,on,O
105027,1,[,O
105027,1,**9-14**,O
105027,1,],O
105027,1,and,O
105027,1,was,O
105027,1,diagnosed,O
105027,1,with,O
105027,1,a,O
105027,1,ruptured,B-Reason
105027,1,ovarian,I-Reason
105027,1,cyst,I-Reason
105027,1,on,O
105027,1,TVUS,O
105027,1,;,O
105027,1,she,O
105027,1,was,O
105027,1,discharged,O
105027,1,on,O
105027,1,oxycodone-APAP,B-Drug
105027,1,.,O
105027,1,On,O
105027,1,[,O
105027,1,**9-15**,O
105027,1,],O
105027,1,she,O
105027,1,developed,O
105027,1,subjective,O
105027,1,fevers/rigors,O
105027,1,",",O
105027,1,increased,O
105027,1,pain,O
105027,1,",",O
105027,1,and,O
105027,1,shortness,O
105027,1,of,O
105027,1,breath,O
105027,1,with,O
105027,1,exertion,O
105027,1,.,O
105027,1,Over,O
105027,1,the,O
105027,1,weekend,O
105027,1,her,O
105027,1,pain,O
105027,1,became,O
105027,1,more,O
105027,1,diffuse,O
105027,1,",",O
105027,1,across,O
105027,1,the,O
105027,1,upper,O
105027,1,abdomen,O
105027,1,.,O
105027,1,She,O
105027,1,then,O
105027,1,re-presented,O
105027,1,on,O
105027,1,[,O
105027,1,**9-18**,O
105027,1,],O
105027,1,to,O
105027,1,[,O
105027,1,**Hospital6,O
105027,1,33**,O
105027,1,],O
105027,1,",",O
105027,1,where,O
105027,1,workup,O
105027,1,included,O
105027,1,a,O
105027,1,CT,O
105027,1,abdomen/pelvis,O
105027,1,with,O
105027,1,evidence,O
105027,1,of,O
105027,1,pyelonephritis,B-Reason
105027,1,.,O
105027,1,She,O
105027,1,was,O
105027,1,given,O
105027,1,a,O
105027,1,dose,O
105027,1,of,O
105027,1,levofloxacin,B-Drug
105027,1,",",O
105027,1,IV,O
105027,1,hydromorphone,B-Drug
105027,1,",",O
105027,1,and,O
105027,1,a,O
105027,1,undefinded,O
105027,1,amount,O
105027,1,of,O
105027,1,IVF,B-Drug
105027,1,.,O
105027,1,Her,O
105027,1,labs,O
105027,1,also,O
105027,1,showed,O
105027,1,platelets,O
105027,1,of,O
105027,1,69K,O
105027,1,",",O
105027,1,low,O
105027,1,WBC,O
105027,1,",",O
105027,1,and,O
105027,1,low,O
105027,1,hematocrit,O
105027,1,around,O
105027,1,32,O
105027,1,(,O
105027,1,substantially,O
105027,1,different,O
105027,1,from,O
105027,1,normal,O
105027,1,values,O
105027,1,on,O
105027,1,[,O
105027,1,**9-14**,O
105027,1,],O
105027,1,),O
105027,1,.,O
105027,1,No,O
105027,1,blood,O
105027,1,or,O
105027,1,urine,O
105027,1,cultures,O
105027,1,were,O
105027,1,obtained,O
105027,1,.,O
105027,1,DIC,O
105027,1,labs,O
105027,1,were,O
105027,1,sent,O
105027,1,and,O
105027,1,revealed,O
105027,1,high,O
105027,1,fibrinogen,O
105027,1,",",O
105027,1,a,O
105027,1,mildly,O
105027,1,elevated,O
105027,1,INR,O
105027,1,",",O
105027,1,smear,O
105027,1,with,O
105027,1,occasional,O
105027,1,schistocytes,O
105027,1,.,O
105027,1,She,O
105027,1,was,O
105027,1,transferred,O
105027,1,to,O
105027,1,[,O
105027,1,**Hospital1,O
105027,1,18**,O
105027,1,],O
105027,1,for,O
105027,1,further,O
105027,1,management,O
105027,1,.,O
105027,1,In,O
105027,1,the,O
105027,1,[,O
105027,1,**Hospital1,O
105027,1,18**,O
105027,1,],O
105027,1,ED,O
105027,1,",",O
105027,1,her,O
105027,1,initial,O
105027,1,vitals,O
105027,1,were,O
105027,1,:,O
105027,1,100.4F,O
105027,1,",",O
105027,1,HR,O
105027,1,124,O
105027,1,",",O
105027,1,BP,O
105027,1,134/92,O
105027,1,",",O
105027,1,RR,O
105027,1,18,O
105027,1,",",O
105027,1,Sat,O
105027,1,99,O
105027,1,%,O
105027,1,(,O
105027,1,on,O
105027,1,room,O
105027,1,air,O
105027,1,),O
105027,1,.,O
105027,1,Repeat,O
105027,1,labs,O
105027,1,again,O
105027,1,demonstrated,O
105027,1,platelets,O
105027,1,of,O
105027,1,60K,O
105027,1,",",O
105027,1,stable,O
105027,1,hematocrit,O
105027,2,at,O
105027,2,31,O
105027,2,",",O
105027,2,elevated,O
105027,2,D-dimer,O
105027,2,",",O
105027,2,fibrinogen,O
105027,2,pending,O
105027,2,.,O
105027,2,Also,O
105027,2,apparently,O
105027,2,with,O
105027,2,new,O
105027,2,decrease,O
105027,2,in,O
105027,2,renal,O
105027,2,function,O
105027,2,.,O
105027,2,Heme-onc,O
105027,2,was,O
105027,2,called,O
105027,2,and,O
105027,2,advised,O
105027,2,to,O
105027,2,wait,O
105027,2,on,O
105027,2,anticoagulation,O
105027,2,;,O
105027,2,they,O
105027,2,would,O
105027,2,see,O
105027,2,the,O
105027,2,patient,O
105027,2,in,O
105027,2,the,O
105027,2,ICU,O
105027,2,.,O
105027,2,Clinically,O
105027,2,",",O
105027,2,she,O
105027,2,looks,O
105027,2,well,O
105027,2,except,O
105027,2,for,O
105027,2,back,B-Reason
105027,2,pain,I-Reason
105027,2,",",O
105027,2,which,O
105027,2,has,O
105027,2,been,O
105027,2,responding,O
105027,2,to,O
105027,2,hydromorphone,B-Drug
105027,2,.,O
105027,2,Vitals,O
105027,2,prior,O
105027,2,to,O
105027,2,transfer,O
105027,2,are,O
105027,2,:,O
105027,2,145/90,O
105027,2,100,O
105027,2,18,O
105027,2,98RA,O
105027,2,.,O
105027,2,In,O
105027,2,the,O
105027,2,ED,O
105027,2,she,O
105027,2,received,O
105027,2,3L,O
105027,2,NS,B-Drug
105027,2,",",O
105027,2,Piperacillin/Tazobactam,B-Drug
105027,2,4.5,O
105027,2,gm,O
105027,2,IV,O
105027,2,",",O
105027,2,vancomycin,B-Drug
105027,2,1gm,O
105027,2,IV,O
105027,2,",",O
105027,2,hydromorphone,B-Drug
105027,2,",",O
105027,2,and,O
105027,2,acetaminophen,B-Drug
105027,2,1gm,O
105027,2,.,O
105027,2,Review,O
105027,2,of,O
105027,2,systems,O
105027,2,:,O
105027,2,+,O
105027,2,chronic,O
105027,2,headaches,O
105027,2,with,O
105027,2,new,O
105027,2,frontal,O
105027,2,headaches,O
105027,2,for,O
105027,2,four,O
105027,2,days,O
105027,2,.,O
105027,2,No,O
105027,2,vision,O
105027,2,or,O
105027,2,hearing,O
105027,2,change,O
105027,2,.,O
105027,2,No,O
105027,2,URI,O
105027,2,symptoms,O
105027,2,.,O
105027,2,No,O
105027,2,N/V,O
105027,2,or,O
105027,2,diarrhea,O
105027,2,.,O
105027,2,No,O
105027,2,blood,O
105027,2,in,O
105027,2,stool,O
105027,2,.,O
105027,2,No,O
105027,2,constipation,O
105027,2,.,O
105027,2,Mild,O
105027,2,urinary,O
105027,2,urgency,O
105027,2,on,O
105027,2,friday,O
105027,2,",",O
105027,2,no,O
105027,2,dysuria,O
105027,2,",",O
105027,2,or,O
105027,2,hematuria,O
105027,2,.,O
105027,2,Mild,O
105027,2,ankle,O
105027,2,swelling,O
105027,2,s/p,O
105027,2,sprain,O
105027,2,.,O
105027,2,No,O
105027,2,weakness,O
105027,2,.,O
105027,2,``,O
105027,2,razor,O
105027,2,burn,O
105027,2,on,O
105027,2,legs,O
105027,2,'',O
105027,2,Pt,O
105027,2,reports,O
105027,2,easy,O
105027,2,bruising,O
105027,2,.,O
105027,2,H/o,O
105027,2,bleeding,O
105027,2,with,O
105027,2,TAH,O
105027,2,requiring,O
105027,2,repeat,O
105027,2,operation,O
105027,2,for,O
105027,2,internal,O
105027,2,bleeding,O
105027,2,.,O
105027,2,No,O
105027,2,h/o,O
105027,2,of,O
105027,2,bleeding,O
105027,2,with,O
105027,2,dental,O
105027,2,work,O
105027,2,.,O
105027,2,no,O
105027,2,history,O
105027,2,of,O
105027,2,clots,O
105027,2,.,O
105027,2,Past,O
105027,2,Medical,O
105027,2,History,O
105027,2,:,O
105027,2,-melanoma,O
105027,2,in,O
105027,2,situ,O
105027,2,excised,O
105027,2,11,O
105027,2,years,O
105027,2,prior,O
105027,2,to,O
105027,2,presentation,O
105027,2,",",O
105027,2,no,O
105027,2,recurrence,O
105027,2,-endometriosis,O
105027,2,-migraines,O
105027,2,-R,O
105027,2,radial,O
105027,2,nerve,O
105027,2,damage,O
105027,2,from,O
105027,2,compression,O
105027,2,-s/p,O
105027,2,TAH/USO,O
105027,2,8,O
105027,2,yrs,O
105027,2,ago,O
105027,2,",",O
105027,2,c/b,O
105027,2,need,O
105027,2,for,O
105027,2,3,O
105027,2,units,O
105027,2,PRBC,B-Drug
105027,2,due,O
105027,2,to,O
105027,2,bleeding,O
105027,2,at,O
105027,2,a,O
105027,2,ligation,O
105027,2,site,O
105027,2,-chronic,O
105027,2,anemia,O
105027,2,Social,O
105027,2,History,O
105027,2,:,O
105027,2,She,O
105027,2,is,O
105027,2,currently,O
105027,2,unemployed,O
105027,2,.,O
105027,2,She,O
105027,2,smokes,O
105027,2,1,O
105027,2,PPD,O
105027,2,since,O
105027,2,a,O
105027,2,teenage,O
105027,2,",",O
105027,2,and,O
105027,2,drinks,O
105027,2,socially,O
105027,2,.,O
105027,2,She,O
105027,2,is,O
105027,2,here,O
105027,2,alone,O
105027,2,",",O
105027,2,and,O
105027,2,denies,O
105027,2,any,O
105027,2,recent,O
105027,2,travel,O
105027,2,or,O
105027,2,insect/tick,O
105027,2,bites,O
105027,2,.,O
105027,2,Family,O
105027,2,History,O
105027,2,:,O
105027,2,Father,O
105027,2,has,O
105027,2,history,O
105027,2,of,O
105027,2,mesenteric,O
105027,2,vein,O
105027,2,thrombosis,O
105027,2,s/p,O
105027,2,small,O
105027,2,intestine,O
105027,2,resection,O
105027,2,;,O
105027,2,with,O
105027,2,h/o,O
105027,2,factor,O
105027,2,V,O
105027,2,leiden,O
105027,2,with,O
105027,2,unknown,O
105027,2,genetic,O
105027,2,profile,O
105027,2,.,O
105027,2,No,O
105027,2,further,O
105027,2,history,O
105027,2,of,O
105027,2,clotting,O
105027,2,or,O
105027,2,bleeding,O
105027,2,disorders,O
105027,2,in,O
105027,2,family,O
105027,2,.,O
105027,2,Physical,O
105027,2,Exam,O
105027,2,:,O
105027,3,GENERAL,O
105027,3,:,O
105027,3,Pleasant,O
105027,3,",",O
105027,3,young,O
105027,3,white,O
105027,3,female,O
105027,3,in,O
105027,3,moderate,O
105027,3,distress,O
105027,3,HEENT,O
105027,3,:,O
105027,3,Normocephalic,O
105027,3,",",O
105027,3,atraumatic,O
105027,3,.,O
105027,3,No,O
105027,3,conjunctival,O
105027,3,pallor,O
105027,3,.,O
105027,3,No,O
105027,3,scleral,O
105027,3,icterus,O
105027,3,.,O
105027,3,PERRLA/EOMI,O
105027,3,.,O
105027,3,Dry,O
105027,3,MM,O
105027,3,.,O
105027,3,OP,O
105027,3,clear,O
105027,3,.,O
105027,3,Neck,O
105027,3,Supple,O
105027,3,",",O
105027,3,No,O
105027,3,LAD,O
105027,3,",",O
105027,3,No,O
105027,3,thyromegaly,O
105027,3,.,O
105027,3,CARDIAC,O
105027,3,:,O
105027,3,Regular,O
105027,3,rhythm,O
105027,3,",",O
105027,3,tachycardic,O
105027,3,.,O
105027,3,Normal,O
105027,3,S1,O
105027,3,",",O
105027,3,S2,O
105027,3,.,O
105027,3,1/6,O
105027,3,SEM,O
105027,3,in,O
105027,3,LUSB,O
105027,3,no,O
105027,3,rubs,O
105027,3,or,O
105027,3,[,O
105027,3,**Last,O
105027,3,Name,O
105027,3,(,O
105027,3,un,O
105027,3,),O
105027,3,549**,O
105027,3,],O
105027,3,.,O
105027,3,JVP=,O
105027,3,2,O
105027,3,cm,O
105027,3,above,O
105027,3,clavicle,O
105027,3,.,O
105027,3,LUNGS,O
105027,3,:,O
105027,3,crackles,O
105027,3,R,O
105027,3,>,O
105027,3,L,O
105027,3,base,O
105027,3,",",O
105027,3,good,O
105027,3,air,O
105027,3,movement,O
105027,3,biaterally,O
105027,3,.,O
105027,3,ABDOMEN,O
105027,3,:,O
105027,3,NABS,O
105027,3,.,O
105027,3,Soft,O
105027,3,",",O
105027,3,ND,O
105027,3,.,O
105027,3,BL,O
105027,3,upper,O
105027,3,quad,O
105027,3,tenderness,O
105027,3,",",O
105027,3,greatest,O
105027,3,in,O
105027,3,RUQ,O
105027,3,.,O
105027,3,gaurding,O
105027,3,in,O
105027,3,RUQ,O
105027,3,without,O
105027,3,rebound,O
105027,3,.,O
105027,3,No,O
105027,3,HSM,O
105027,3,Left,O
105027,3,CVA,O
105027,3,tenderness,O
105027,3,.,O
105027,3,EXTREMITIES,O
105027,3,:,O
105027,3,No,O
105027,3,edema,O
105027,3,or,O
105027,3,calf,O
105027,3,pain,O
105027,3,",",O
105027,3,2+,O
105027,3,dorsalis,O
105027,3,pedis/,O
105027,3,posterior,O
105027,3,tibial,O
105027,3,pulses,O
105027,3,.,O
105027,3,SKIN,O
105027,3,:,O
105027,3,1mm,O
105027,3,erthyematous,O
105027,3,macules,O
105027,3,at,O
105027,3,sites,O
105027,3,of,O
105027,3,follicules,O
105027,3,on,O
105027,3,BL,O
105027,3,shins,O
105027,3,.,O
105027,3,No,O
105027,3,ecchymoses,O
105027,3,.,O
105027,3,NEURO,O
105027,3,:,O
105027,3,A,O
105027,3,&,O
105027,3,Ox3,O
105027,3,.,O
105027,3,Appropriate,O
105027,3,.,O
105027,3,CN,O
105027,3,2-12,O
105027,3,grossly,O
105027,3,intact,O
105027,3,.,O
105027,3,Preserved,O
105027,3,sensation,O
105027,3,throughout,O
105027,3,.,O
105027,3,5/5,O
105027,3,strength,O
105027,3,throughout,O
105027,3,except,O
105027,3,[,O
105027,3,**2-1**,O
105027,3,],O
105027,3,with,O
105027,3,left,O
105027,3,hand,O
105027,3,grip,O
105027,3,.,O
105027,3,[,O
105027,3,**12-1**,O
105027,3,],O
105027,3,+,O
105027,3,reflexes,O
105027,3,",",O
105027,3,equal,O
105027,3,BL,O
105027,3,.,O
105027,3,Gait,O
105027,3,assessment,O
105027,3,deferred,O
105027,3,.,O
105027,3,NL,O
105027,3,coordination,O
105027,3,.,O
105027,3,PSYCH,O
105027,3,:,O
105027,3,Listens,O
105027,3,and,O
105027,3,responds,O
105027,3,to,O
105027,3,questions,O
105027,3,appropriately,O
105027,3,",",O
105027,3,pleasant,O
105027,3,Pertinent,O
105027,3,Results,O
105027,3,:,O
105027,3,===================,O
105027,3,LABORATORY,O
105027,3,RESULTS,O
105027,3,===================,O
105027,3,On,O
105027,3,Admission,O
105027,3,:,O
105027,3,WBC-3.7*,O
105027,3,RBC-2.98*,O
105027,3,Hgb-10.4*,O
105027,3,Hct-31.2*,O
105027,3,MCV-105*,O
105027,3,RDW-14.6,O
105027,3,Plt,O
105027,3,Ct-60*,O
105027,3,Na,O
105027,3,138,O
105027,3,",",O
105027,3,K,O
105027,3,3*,O
105027,3,",",O
105027,3,Cl,O
105027,3,109*,O
105027,3,",",O
105027,3,HCO3*,O
105027,3,BUN,O
105027,3,21*,O
105027,3,",",O
105027,3,Cr,O
105027,3,1.2*,O
105027,3,",",O
105027,3,Glu,O
105027,3,92,O
105027,3,PT-13.5*,O
105027,3,PTT-25.5,O
105027,3,INR,O
105027,3,(,O
105027,3,PT,O
105027,3,),O
105027,3,-1.2*,O
105027,3,ALT-25,O
105027,3,AST-24,O
105027,3,LD,O
105027,3,(,O
105027,3,LDH,O
105027,3,),O
105027,3,-466*,O
105027,3,AlkPhos-104,O
105027,3,TotBili-0.4,O
105027,3,On,O
105027,3,Discharge,O
105027,3,:,O
105027,3,WBC-12.2*,O
105027,3,RBC-3.04*,O
105027,3,#,O
105027,3,Hgb-9.2*,O
105027,3,#,O
105027,3,Hct-29.0*,O
105027,3,#,O
105027,3,MCV-95,O
105027,3,RDW-17.8*,O
105027,3,Plt,O
105027,3,Ct-183,O
105027,3,19.3*,O
105027,3,PTT-31.8,O
105027,3,INR,O
105027,3,(,O
105027,3,PT,O
105027,3,),O
105027,3,-1.8*,O
105027,3,Other,O
105027,3,Important,O
105027,3,Labs,O
105027,3,:,O
105027,3,Lupus-NEG,O
105027,3,ACA,O
105027,3,IgG-11.4,O
105027,3,ACA,O
105027,3,IgM-16.6*,O
105027,3,AT,O
105027,3,III-70,O
105027,3,ANCA-NEGATIVE,O
105027,3,B,O
105027,3,RheuFac-65*,O
105027,3,C3-89*,O
105027,3,C4-8*,O
105027,3,HIV,O
105027,3,Ab-NEGATIVE,O
105027,3,FACTOR,O
105027,3,V,O
105027,3,LEIDEN-Test,O
105027,3,negative,O
105027,3,=============,O
105027,3,MICROBIOLOGY,O
105027,4,=============,O
105027,4,Blood,O
105027,4,Cultures*23,O
105027,4,:,O
105027,4,No,O
105027,4,Growth,O
105027,4,To,O
105027,4,Date,O
105027,4,Urine,O
105027,4,Culture,O
105027,4,*,O
105027,4,9,O
105027,4,:,O
105027,4,No,O
105027,4,Growth,O
105027,4,To,O
105027,4,Date,O
105027,4,===============================,O
105027,4,Radiology,O
105027,4,AND,O
105027,4,OTHER,O
105027,4,STRATEGIES,O
105027,4,===============================,O
105027,4,ECG,O
105027,4,[,O
105027,4,**2125-9-18**,O
105027,4,],O
105027,4,:,O
105027,4,Sinus,O
105027,4,tachycardia,O
105027,4,.,O
105027,4,Poor,O
105027,4,R,O
105027,4,wave,O
105027,4,progression,O
105027,4,is,O
105027,4,probably,O
105027,4,a,O
105027,4,normal,O
105027,4,variant,O
105027,4,.,O
105027,4,Diffuse,O
105027,4,T,O
105027,4,wave,O
105027,4,changes,O
105027,4,that,O
105027,4,are,O
105027,4,non-specific,O
105027,4,.,O
105027,4,No,O
105027,4,previous,O
105027,4,tracing,O
105027,4,available,O
105027,4,for,O
105027,4,comparison,O
105027,4,.,O
105027,4,Chest,O
105027,4,Radiograph,O
105027,4,[,O
105027,4,**2125-9-18**,O
105027,4,],O
105027,4,:,O
105027,4,IMPRESSION,O
105027,4,:,O
105027,4,Mild,O
105027,4,interstitial,O
105027,4,edema,O
105027,4,.,O
105027,4,Small,O
105027,4,left,O
105027,4,effusion,O
105027,4,.,O
105027,4,Ultrasound,O
105027,4,of,O
105027,4,Abdomen,O
105027,4,[,O
105027,4,**2125-9-18**,O
105027,4,],O
105027,4,:,O
105027,4,IMPRESSION,O
105027,4,:,O
105027,4,1,O
105027,4,.,O
105027,4,Enlarged,O
105027,4,and,O
105027,4,heterogeneous,O
105027,4,left,O
105027,4,kidney,O
105027,4,",",O
105027,4,consistent,O
105027,4,with,O
105027,4,given,O
105027,4,history,O
105027,4,of,O
105027,4,pyelonephritis,O
105027,4,",",O
105027,4,with,O
105027,4,a,O
105027,4,number,O
105027,4,of,O
105027,4,hypoechoic,O
105027,4,areas,O
105027,4,in,O
105027,4,the,O
105027,4,upper,O
105027,4,pole,O
105027,4,potentially,O
105027,4,suspicious,O
105027,4,for,O
105027,4,abscess,O
105027,4,.,O
105027,4,No,O
105027,4,evidence,O
105027,4,of,O
105027,4,hydronephrosis,O
105027,4,.,O
105027,4,2,O
105027,4,.,O
105027,4,Nondistended,O
105027,4,gallbladder,O
105027,4,with,O
105027,4,gallbladder,O
105027,4,wall,O
105027,4,edema,O
105027,4,likely,O
105027,4,secondary,O
105027,4,to,O
105027,4,third,O
105027,4,spacing,O
105027,4,.,O
105027,4,No,O
105027,4,specific,O
105027,4,son,O
105027,4,[,O
105027,4,**Name,O
105027,4,(,O
105027,4,NI,O
105027,4,),O
105027,4,493**,O
105027,4,],O
105027,4,evidence,O
105027,4,for,O
105027,4,cholecystitis,O
105027,4,.,O
105027,4,3,O
105027,4,.,O
105027,4,The,O
105027,4,CBD,O
105027,4,is,O
105027,4,dilated,O
105027,4,measuring,O
105027,4,0.8,O
105027,4,cm,O
105027,4,without,O
105027,4,intrahepatic,O
105027,4,bile,O
105027,4,dilatation,O
105027,4,.,O
105027,4,4,O
105027,4,.,O
105027,4,Patent,O
105027,4,portal,O
105027,4,vein,O
105027,4,.,O
105027,4,CT,O
105027,4,Abdomen,O
105027,4,and,O
105027,4,Pelvis,O
105027,4,W/Contrast,O
105027,4,[,O
105027,4,**2125-9-18**,O
105027,4,],O
105027,4,:,O
105027,4,IMPRESSION,O
105027,4,:,O
105027,4,1,O
105027,4,.,O
105027,4,Severe,O
105027,4,acute,O
105027,4,left,O
105027,4,pyelonephritis,O
105027,4,with,O
105027,4,marked,O
105027,4,renal,O
105027,4,edema,O
105027,4,",",O
105027,4,evolving,O
105027,4,foci,O
105027,4,of,O
105027,4,hypoperfusion,O
105027,4,",",O
105027,4,parenchymal,O
105027,4,necrosis,O
105027,4,",",O
105027,4,inflammatory,O
105027,4,phlegmon,O
105027,4,or,O
105027,4,early,O
105027,4,abscess,O
105027,4,formation,O
105027,4,.,O
105027,4,2,O
105027,4,.,O
105027,4,Multiple,O
105027,4,pulmonary,O
105027,4,nodules,O
105027,4,measuring,O
105027,4,up,O
105027,4,to,O
105027,4,4,O
105027,4,mm,O
105027,4,in,O
105027,4,the,O
105027,4,left,O
105027,4,lower,O
105027,4,lobe,O
105027,4,.,O
105027,4,In,O
105027,4,the,O
105027,4,setting,O
105027,4,of,O
105027,4,infection,O
105027,4,",",O
105027,4,these,O
105027,4,could,O
105027,4,reflect,O
105027,4,septic,O
105027,4,emboli,O
105027,4,or,O
105027,4,other,O
105027,4,infectious,O
105027,4,processes,O
105027,4,.,O
105027,4,Followup,O
105027,4,chest,O
105027,4,CT,O
105027,4,to,O
105027,4,document,O
105027,4,resolution,O
105027,4,is,O
105027,4,recommended,O
105027,4,.,O
105027,4,3,O
105027,4,.,O
105027,4,Bilateral,O
105027,4,pleural,O
105027,4,effusions,O
105027,4,and,O
105027,4,basilar,O
105027,4,consolidations,O
105027,4,could,O
105027,4,reflect,O
105027,4,atelectasis,O
105027,4,and/or,O
105027,4,superimposed,O
105027,4,pneumonia,O
105027,4,.,O
105027,4,4,O
105027,4,.,O
105027,4,Gallbladder,O
105027,4,wall,O
105027,4,edema,O
105027,4,",",O
105027,4,pericholecystic,O
105027,4,fluid,O
105027,4,and,O
105027,4,pericholecystic,O
105027,4,hepatic,O
105027,4,parenchymal,O
105027,4,hyperemia,O
105027,4,",",O
105027,4,unchanged,O
105027,4,from,O
105027,4,prior,O
105027,4,ultrasound,O
105027,4,.,O
105027,4,While,O
105027,4,these,O
105027,4,findings,O
105027,4,are,O
105027,4,felt,O
105027,4,likely,O
105027,4,reactive,O
105027,4,in,O
105027,4,the,O
105027,4,setting,O
105027,4,of,O
105027,4,other,O
105027,4,abnormalities,O
105027,4,(,O
105027,4,particularly,O
105027,4,since,O
105027,4,the,O
105027,4,gallbladder,O
105027,4,does,O
105027,4,not,O
105027,4,appear,O
105027,4,distended,O
105027,4,),O
105027,4,",",O
105027,5,by,O
105027,5,imaging,O
105027,5,this,O
105027,5,is,O
105027,5,equivocal,O
105027,5,for,O
105027,5,acute,O
105027,5,cholecystitis,O
105027,5,",",O
105027,5,and,O
105027,5,therefore,O
105027,5,if,O
105027,5,there,O
105027,5,is,O
105027,5,clinical,O
105027,5,concern,O
105027,5,a,O
105027,5,HIDA,O
105027,5,scan,O
105027,5,may,O
105027,5,be,O
105027,5,considered,O
105027,5,.,O
105027,5,MRI,O
105027,5,Abdomen,O
105027,5,W,O
105027,5,and,O
105027,5,W/O,O
105027,5,Contrast,O
105027,5,[,O
105027,5,**2125-9-18**,O
105027,5,],O
105027,5,:,O
105027,5,IMPRESSION,O
105027,5,:,O
105027,5,1,O
105027,5,.,O
105027,5,Acute,O
105027,5,infarction,O
105027,5,involving,O
105027,5,much,O
105027,5,of,O
105027,5,the,O
105027,5,upper,O
105027,5,pole,O
105027,5,and,O
105027,5,interpolar,O
105027,5,region,O
105027,5,of,O
105027,5,the,O
105027,5,left,O
105027,5,kidney,O
105027,5,",",O
105027,5,coexistent,O
105027,5,pyelonephritis,O
105027,5,is,O
105027,5,possible,O
105027,5,.,O
105027,5,Two,O
105027,5,small,O
105027,5,discrete,O
105027,5,regions,O
105027,5,of,O
105027,5,fluid,O
105027,5,signal,O
105027,5,intensity,O
105027,5,may,O
105027,5,be,O
105027,5,explained,O
105027,5,by,O
105027,5,necrosis,O
105027,5,",",O
105027,5,although,O
105027,5,abscess,O
105027,5,formation,O
105027,5,can,O
105027,5,not,O
105027,5,be,O
105027,5,excluded,O
105027,5,.,O
105027,5,2,O
105027,5,.,O
105027,5,Irregularity,O
105027,5,of,O
105027,5,bilateral,O
105027,5,renal,O
105027,5,arteries,O
105027,5,though,O
105027,5,confidence,O
105027,5,in,O
105027,5,that,O
105027,5,finding,O
105027,5,is,O
105027,5,low,O
105027,5,due,O
105027,5,to,O
105027,5,motion,O
105027,5,and,O
105027,5,potential,O
105027,5,artifact,O
105027,5,-,O
105027,5,fibromuscular,O
105027,5,dysplasia,O
105027,5,or,O
105027,5,vasculitis,O
105027,5,can,O
105027,5,have,O
105027,5,this,O
105027,5,appearance,O
105027,5,.,O
105027,5,A,O
105027,5,repeat,O
105027,5,study,O
105027,5,of,O
105027,5,the,O
105027,5,renal,O
105027,5,arteries,O
105027,5,is,O
105027,5,suggested,O
105027,5,when,O
105027,5,the,O
105027,5,patient,O
105027,5,is,O
105027,5,more,O
105027,5,stable,O
105027,5,.,O
105027,5,3,O
105027,5,.,O
105027,5,Gallbladder,O
105027,5,wall,O
105027,5,edema,O
105027,5,is,O
105027,5,commonly,O
105027,5,seen,O
105027,5,with,O
105027,5,third,O
105027,5,spacing,O
105027,5,of,O
105027,5,fluid,O
105027,5,.,O
105027,5,Common,O
105027,5,bile,O
105027,5,duct,O
105027,5,dilated,O
105027,5,to,O
105027,5,9,O
105027,5,mm,O
105027,5,",",O
105027,5,but,O
105027,5,has,O
105027,5,normal,O
105027,5,distal,O
105027,5,smooth,O
105027,5,tapering,O
105027,5,and,O
105027,5,there,O
105027,5,is,O
105027,5,no,O
105027,5,evidence,O
105027,5,of,O
105027,5,cholelithiasis,O
105027,5,or,O
105027,5,choledocholithiasis,O
105027,5,.,O
105027,5,4,O
105027,5,.,O
105027,5,Small,O
105027,5,bilateral,O
105027,5,pleural,O
105027,5,effusions,O
105027,5,and,O
105027,5,atelectasis,O
105027,5,and/or,O
105027,5,consolidation,O
105027,5,at,O
105027,5,the,O
105027,5,lung,O
105027,5,bases,O
105027,5,.,O
105027,5,CT,O
105027,5,Chest,O
105027,5,W/O,O
105027,5,Contrast,O
105027,5,[,O
105027,5,**2125-9-22**,O
105027,5,],O
105027,5,:,O
105027,5,IMPRESSION,O
105027,5,:,O
105027,5,1,O
105027,5,.,O
105027,5,Diffuse,O
105027,5,ground-glass,O
105027,5,opacity,O
105027,5,primarily,O
105027,5,within,O
105027,5,the,O
105027,5,bilateral,O
105027,5,upper,O
105027,5,lobes,O
105027,5,.,O
105027,5,Differential,O
105027,5,diagnosis,O
105027,5,includes,O
105027,5,atypical,O
105027,5,infectious,O
105027,5,pneumonia,O
105027,5,",",O
105027,5,such,O
105027,5,as,O
105027,5,PCP,O
105027,5,",",O
105027,5,[,O
105027,5,**Name10,O
105027,5,(,O
105027,5,NameIs,O
105027,5,),O
105027,5,84655**,O
105027,5,],O
105027,5,pneumonia,O
105027,5,and,O
105027,5,pulmonary,O
105027,5,edema/hemorrhage,O
105027,5,.,O
105027,5,2,O
105027,5,.,O
105027,5,Bilateral,O
105027,5,pleural,O
105027,5,effusions,O
105027,5,",",O
105027,5,left,O
105027,5,greater,O
105027,5,than,O
105027,5,right,O
105027,5,.,O
105027,5,3,O
105027,5,.,O
105027,5,Emphysematous,O
105027,5,changes,O
105027,5,.,O
105027,5,TTE,O
105027,5,[,O
105027,5,**2125-9-24**,O
105027,5,],O
105027,5,:,O
105027,5,Conclusions,O
105027,5,No,O
105027,5,thrombus/mass,O
105027,5,is,O
105027,5,seen,O
105027,5,in,O
105027,5,the,O
105027,5,body,O
105027,5,of,O
105027,5,the,O
105027,5,left,O
105027,5,atrium,O
105027,5,.,O
105027,5,A,O
105027,5,patent,O
105027,5,foramen,O
105027,5,ovale,O
105027,5,is,O
105027,5,present,O
105027,5,.,O
105027,5,Left,O
105027,5,ventricular,O
105027,5,wall,O
105027,5,thickness,O
105027,5,",",O
105027,5,cavity,O
105027,5,size,O
105027,5,",",O
105027,5,and,O
105027,5,global,O
105027,5,systolic,O
105027,5,function,O
105027,5,are,O
105027,5,normal,O
105027,5,(,O
105027,5,LVEF,O
105027,5,>,O
105027,5,55,O
105027,5,%,O
105027,5,),O
105027,5,.,O
105027,5,No,O
105027,5,masses,O
105027,5,or,O
105027,5,thrombi,O
105027,5,are,O
105027,5,seen,O
105027,5,in,O
105027,5,the,O
105027,5,left,O
105027,5,ventricle,O
105027,5,.,O
105027,5,Right,O
105027,5,ventricular,O
105027,5,chamber,O
105027,6,size,O
105027,6,and,O
105027,6,free,O
105027,6,wall,O
105027,6,motion,O
105027,6,are,O
105027,6,normal,O
105027,6,.,O
105027,6,The,O
105027,6,aortic,O
105027,6,valve,O
105027,6,leaflets,O
105027,6,(,O
105027,6,3,O
105027,6,),O
105027,6,appear,O
105027,6,structurally,O
105027,6,normal,O
105027,6,with,O
105027,6,good,O
105027,6,leaflet,O
105027,6,excursion,O
105027,6,and,O
105027,6,no,O
105027,6,aortic,O
105027,6,regurgitation,O
105027,6,.,O
105027,6,No,O
105027,6,masses,O
105027,6,or,O
105027,6,vegetations,O
105027,6,are,O
105027,6,seen,O
105027,6,on,O
105027,6,the,O
105027,6,aortic,O
105027,6,valve,O
105027,6,.,O
105027,6,The,O
105027,6,mitral,O
105027,6,valve,O
105027,6,appears,O
105027,6,structurally,O
105027,6,normal,O
105027,6,with,O
105027,6,trivial,O
105027,6,mitral,O
105027,6,regurgitation,O
105027,6,.,O
105027,6,There,O
105027,6,is,O
105027,6,no,O
105027,6,mitral,O
105027,6,valve,O
105027,6,prolapse,O
105027,6,.,O
105027,6,No,O
105027,6,mass,O
105027,6,or,O
105027,6,vegetation,O
105027,6,is,O
105027,6,seen,O
105027,6,on,O
105027,6,the,O
105027,6,mitral,O
105027,6,valve,O
105027,6,.,O
105027,6,The,O
105027,6,pulmonary,O
105027,6,artery,O
105027,6,systolic,O
105027,6,pressure,O
105027,6,could,O
105027,6,not,O
105027,6,be,O
105027,6,determined,O
105027,6,.,O
105027,6,There,O
105027,6,is,O
105027,6,a,O
105027,6,trivial/physiologic,O
105027,6,pericardial,O
105027,6,effusion,O
105027,6,.,O
105027,6,Compared,O
105027,6,with,O
105027,6,the,O
105027,6,prior,O
105027,6,study,O
105027,6,(,O
105027,6,images,O
105027,6,reviewed,O
105027,6,),O
105027,6,of,O
105027,6,[,O
105027,6,**2125-9-18**,O
105027,6,],O
105027,6,",",O
105027,6,a,O
105027,6,patent,O
105027,6,foramen,O
105027,6,ovale,O
105027,6,is,O
105027,6,seen,O
105027,6,.,O
105027,6,MRA,O
105027,6,Kidney,O
105027,6,W/,O
105027,6,and,O
105027,6,W/O,O
105027,6,Contrast,O
105027,6,[,O
105027,6,**2125-9-24**,O
105027,6,],O
105027,6,:,O
105027,6,IMPRESSION,O
105027,6,:,O
105027,6,1,O
105027,6,.,O
105027,6,Enlarged,O
105027,6,left,O
105027,6,kidney,O
105027,6,",",O
105027,6,with,O
105027,6,large,O
105027,6,",",O
105027,6,wedge-shaped,O
105027,6,areas,O
105027,6,of,O
105027,6,liquefactive,O
105027,6,necrosis,O
105027,6,at,O
105027,6,the,O
105027,6,upper,O
105027,6,pole,O
105027,6,and,O
105027,6,interpolar,O
105027,6,region,O
105027,6,.,O
105027,6,The,O
105027,6,areas,O
105027,6,of,O
105027,6,involvement,O
105027,6,are,O
105027,6,unchanged,O
105027,6,in,O
105027,6,size,O
105027,6,and,O
105027,6,appearance,O
105027,6,.,O
105027,6,While,O
105027,6,abscesses,O
105027,6,can,O
105027,6,not,O
105027,6,be,O
105027,6,completely,O
105027,6,excluded,O
105027,6,",",O
105027,6,the,O
105027,6,presence,O
105027,6,of,O
105027,6,preserved,O
105027,6,capsular,O
105027,6,enhancement,O
105027,6,",",O
105027,6,and,O
105027,6,the,O
105027,6,absence,O
105027,6,of,O
105027,6,extensive,O
105027,6,edema,O
105027,6,or,O
105027,6,perinephric,O
105027,6,inflammatory,O
105027,6,changes,O
105027,6,is,O
105027,6,more,O
105027,6,consistent,O
105027,6,with,O
105027,6,multifocal,O
105027,6,infarct,O
105027,6,.,O
105027,6,Given,O
105027,6,the,O
105027,6,clinical,O
105027,6,presentation,O
105027,6,",",O
105027,6,MR,O
105027,6,findings,O
105027,6,are,O
105027,6,most,O
105027,6,consistent,O
105027,6,with,O
105027,6,multiple,O
105027,6,renal,O
105027,6,infarcts,O
105027,6,in,O
105027,6,the,O
105027,6,setting,O
105027,6,of,O
105027,6,pyelonephritis,O
105027,6,.,O
105027,6,2,O
105027,6,.,O
105027,6,Normal,O
105027,6,renal,O
105027,6,vasculature,O
105027,6,",",O
105027,6,with,O
105027,6,no,O
105027,6,abnormalities,O
105027,6,of,O
105027,6,the,O
105027,6,renal,O
105027,6,arteries,O
105027,6,to,O
105027,6,suggest,O
105027,6,fibromuscular,O
105027,6,dysplasia,O
105027,6,or,O
105027,6,vasculitis,O
105027,6,.,O
105027,6,Widely,O
105027,6,patent,O
105027,6,left,O
105027,6,renal,O
105027,6,vein,O
105027,6,without,O
105027,6,filling,O
105027,6,defect,O
105027,6,.,O
105027,6,3,O
105027,6,.,O
105027,6,Moderate,O
105027,6,left,O
105027,6,and,O
105027,6,small,O
105027,6,right,O
105027,6,pleural,O
105027,6,effusions,O
105027,6,with,O
105027,6,atelectasis,O
105027,6,.,O
105027,6,Bilateral,O
105027,6,Lower,O
105027,6,Extremity,O
105027,6,Ultrasounds,O
105027,6,[,O
105027,6,**2125-9-25**,O
105027,6,],O
105027,6,:,O
105027,6,IMPRESSION,O
105027,6,:,O
105027,6,1,O
105027,6,.,O
105027,6,No,O
105027,6,evidence,O
105027,6,of,O
105027,6,DVT,O
105027,6,in,O
105027,6,the,O
105027,6,lower,O
105027,6,extremities,O
105027,6,.,O
105027,6,CTA,O
105027,6,Chest,O
105027,6,W/,O
105027,6,and,O
105027,6,W/O,O
105027,6,Contrast,O
105027,6,[,O
105027,6,**2125-9-26**,O
105027,6,],O
105027,6,:,O
105027,6,IMPRESSION,O
105027,6,:,O
105027,6,1,O
105027,6,.,O
105027,6,No,O
105027,6,pulmonary,O
105027,6,embolus,O
105027,6,.,O
105027,6,No,O
105027,6,aortic,O
105027,6,dissection,O
105027,6,.,O
105027,6,2,O
105027,6,.,O
105027,6,Resolved,O
105027,6,right,O
105027,6,pleural,O
105027,6,effusion,O
105027,6,and,O
105027,6,persistent,O
105027,6,but,O
105027,6,now,O
105027,6,slightly,O
105027,6,loculated,O
105027,6,moderate,O
105027,6,left,O
105027,7,pleural,O
105027,7,effusion,O
105027,7,with,O
105027,7,associated,O
105027,7,atelectasis,O
105027,7,.,O
105027,7,3,O
105027,7,.,O
105027,7,Decreased,O
105027,7,ground-glass,O
105027,7,opacification,O
105027,7,in,O
105027,7,the,O
105027,7,background,O
105027,7,of,O
105027,7,persistent,O
105027,7,emphysema,O
105027,7,.,O
105027,7,4,O
105027,7,.,O
105027,7,Incompletely,O
105027,7,characterized,O
105027,7,right,O
105027,7,kidney,O
105027,7,abnormality,O
105027,7,RUQ,O
105027,7,Ultrasound,O
105027,7,[,O
105027,7,**2125-9-28**,O
105027,7,],O
105027,7,:,O
105027,7,IMPRESSION,O
105027,7,:,O
105027,7,1,O
105027,7,.,O
105027,7,Non-distended,O
105027,7,gallbladder,O
105027,7,",",O
105027,7,with,O
105027,7,no,O
105027,7,pericholecystic,O
105027,7,fluid,O
105027,7,or,O
105027,7,cholelithiasis,O
105027,7,.,O
105027,7,No,O
105027,7,specific,O
105027,7,son,O
105027,7,[,O
105027,7,**Name,O
105027,7,(,O
105027,7,NI,O
105027,7,),O
105027,7,493**,O
105027,7,],O
105027,7,evidence,O
105027,7,for,O
105027,7,cholecystitis,O
105027,7,.,O
105027,7,2,O
105027,7,.,O
105027,7,Persistent,O
105027,7,dilatation,O
105027,7,of,O
105027,7,the,O
105027,7,common,O
105027,7,bile,O
105027,7,duct,O
105027,7,without,O
105027,7,intrahepatic,O
105027,7,bile,O
105027,7,duct,O
105027,7,dilatation,O
105027,7,.,O
105027,7,No,O
105027,7,son,O
105027,7,[,O
105027,7,**Name,O
105027,7,(,O
105027,7,NI,O
105027,7,),O
105027,7,493**,O
105027,7,],O
105027,7,evidence,O
105027,7,for,O
105027,7,choledocholithiasis,O
105027,7,within,O
105027,7,the,O
105027,7,visualized,O
105027,7,common,O
105027,7,duct,O
105027,7,.,O
105027,7,Chest,O
105027,7,Radiograph,O
105027,7,[,O
105027,7,**2125-10-2**,O
105027,7,],O
105027,7,:,O
105027,7,IMPRESSION,O
105027,7,:,O
105027,7,Small,O
105027,7,stable,O
105027,7,left,O
105027,7,pleural,O
105027,7,effusion,O
105027,7,",",O
105027,7,with,O
105027,7,no,O
105027,7,evidence,O
105027,7,of,O
105027,7,pneumothorax,O
105027,7,.,O
105027,7,MRI,O
105027,7,Abdomen,O
105027,7,W/,O
105027,7,and,O
105027,7,W/O,O
105027,7,Contrast,O
105027,7,[,O
105027,7,**2125-10-4**,O
105027,7,],O
105027,7,:,O
105027,7,IMPRESSION,O
105027,7,:,O
105027,7,1,O
105027,7,.,O
105027,7,No,O
105027,7,new,O
105027,7,areas,O
105027,7,of,O
105027,7,infarction,O
105027,7,within,O
105027,7,the,O
105027,7,left,O
105027,7,kidney,O
105027,7,compared,O
105027,7,to,O
105027,7,multiple,O
105027,7,prior,O
105027,7,studies,O
105027,7,.,O
105027,7,Areas,O
105027,7,of,O
105027,7,T2,O
105027,7,signal,O
105027,7,hyperintensity,O
105027,7,within,O
105027,7,the,O
105027,7,lateral,O
105027,7,interpolar,O
105027,7,region,O
105027,7,and,O
105027,7,upper,O
105027,7,pole,O
105027,7,of,O
105027,7,the,O
105027,7,left,O
105027,7,kidney,O
105027,7,corresponding,O
105027,7,to,O
105027,7,stable,O
105027,7,areas,O
105027,7,of,O
105027,7,absent,O
105027,7,contrast,O
105027,7,enhancement,O
105027,7,in,O
105027,7,addition,O
105027,7,to,O
105027,7,striated,O
105027,7,enhancement,O
105027,7,within,O
105027,7,the,O
105027,7,left,O
105027,7,lower,O
105027,7,pole,O
105027,7,.,O
105027,7,These,O
105027,7,findings,O
105027,7,represent,O
105027,7,features,O
105027,7,of,O
105027,7,both,O
105027,7,pyelonephritis,O
105027,7,and,O
105027,7,infarction,O
105027,7,.,O
105027,7,Small,O
105027,7,vessel,O
105027,7,vasculitis,O
105027,7,should,O
105027,7,be,O
105027,7,included,O
105027,7,in,O
105027,7,the,O
105027,7,differential,O
105027,7,.,O
105027,7,2,O
105027,7,.,O
105027,7,Resolution,O
105027,7,of,O
105027,7,right,O
105027,7,pleural,O
105027,7,effusion,O
105027,7,with,O
105027,7,decrease,O
105027,7,in,O
105027,7,size,O
105027,7,of,O
105027,7,small,O
105027,7,left,O
105027,7,pleural,O
105027,7,effusion,O
105027,7,.,O
105027,7,Brief,O
105027,7,Hospital,O
105027,7,Course,O
105027,7,:,O
105027,7,37,O
105027,7,year,O
105027,7,old,O
105027,7,female,O
105027,7,with,O
105027,7,acute,O
105027,7,onset,O
105027,7,thyrombocytopenia,O
105027,7,and,O
105027,7,sepsis,O
105027,7,likely,O
105027,7,secondary,O
105027,7,to,O
105027,7,renal,O
105027,7,infarction,O
105027,7,and,O
105027,7,pyelonephritis,O
105027,7,.,O
105027,7,1,O
105027,7,),O
105027,7,SIRS/Sepsis,B-Reason
105027,7,:,O
105027,7,Patient,O
105027,7,initially,O
105027,7,presented,O
105027,7,with,O
105027,7,left,O
105027,7,flank,O
105027,7,pain,O
105027,7,",",O
105027,7,tachycardia,O
105027,7,",",O
105027,7,low,O
105027,7,WBC,O
105027,7,",",O
105027,7,and,O
105027,7,low,O
105027,7,platelets,O
105027,7,.,O
105027,7,Based,O
105027,7,on,O
105027,7,OSH,O
105027,7,non-contrast,O
105027,7,CT,O
105027,7,scan,O
105027,7,it,O
105027,7,appeared,O
105027,7,this,O
105027,7,was,O
105027,7,consistent,O
105027,7,with,O
105027,7,pyelonephritis,O
105027,7,.,O
105027,7,She,O
105027,7,was,O
105027,7,started,O
105027,7,on,O
105027,7,cefepime,B-Drug
105027,7,",",O
105027,7,flagyl,B-Drug
105027,7,and,O
105027,7,vancomycin,B-Drug
105027,7,[,O
105027,7,**9-19**,O
105027,7,],O
105027,7,.,O
105027,7,With,O
105027,7,concern,O
105027,7,for,O
105027,7,worsening,O
105027,7,abdominal,O
105027,7,pain,O
105027,7,a,O
105027,7,repeat,O
105027,7,contrast,O
105027,7,abdominal,O
105027,7,and,O
105027,7,pelvic,O
105027,7,CT,O
105027,7,was,O
105027,7,performed,O
105027,7,.,O
105027,8,It,O
105027,8,showed,O
105027,8,severe,O
105027,8,acute,O
105027,8,left,O
105027,8,pyelonephritis,O
105027,8,with,O
105027,8,marked,O
105027,8,renal,O
105027,8,edema,O
105027,8,and,O
105027,8,evolving,O
105027,8,foci,O
105027,8,of,O
105027,8,hypoperfusion,O
105027,8,",",O
105027,8,parenchymal,O
105027,8,necrosis,O
105027,8,",",O
105027,8,inflammatory,O
105027,8,phlegmon,O
105027,8,or,O
105027,8,early,O
105027,8,abscess,O
105027,8,formation,O
105027,8,.,O
105027,8,Urology,O
105027,8,was,O
105027,8,consulted,O
105027,8,given,O
105027,8,concern,O
105027,8,for,O
105027,8,a,O
105027,8,need,O
105027,8,for,O
105027,8,acute,O
105027,8,surgical,O
105027,8,management,O
105027,8,.,O
105027,8,They,O
105027,8,suggested,O
105027,8,a,O
105027,8,concern,O
105027,8,for,O
105027,8,renal,O
105027,8,vein/artery,O
105027,8,thrombosis,O
105027,8,due,O
105027,8,to,O
105027,8,the,O
105027,8,appearance,O
105027,8,of,O
105027,8,multifocal,O
105027,8,necrosis,O
105027,8,in,O
105027,8,the,O
105027,8,kidney,O
105027,8,.,O
105027,8,MRI,O
105027,8,revealed,O
105027,8,no,O
105027,8,acute,O
105027,8,thrombosis,O
105027,8,but,O
105027,8,was,O
105027,8,suggestive,O
105027,8,of,O
105027,8,an,O
105027,8,acute,O
105027,8,infarction,O
105027,8,involving,O
105027,8,much,O
105027,8,of,O
105027,8,the,O
105027,8,upper,O
105027,8,pole,O
105027,8,and,O
105027,8,interpolar,O
105027,8,region,O
105027,8,of,O
105027,8,the,O
105027,8,left,O
105027,8,kidney,O
105027,8,without,O
105027,8,being,O
105027,8,able,O
105027,8,to,O
105027,8,rule,O
105027,8,out,O
105027,8,coexistent,O
105027,8,pyelonephritis,O
105027,8,.,O
105027,8,The,O
105027,8,patient,O
105027,8,'s,O
105027,8,white,B-Reason
105027,8,count,I-Reason
105027,8,eventually,I-Reason
105027,8,trended,I-Reason
105027,8,up,I-Reason
105027,8,from,O
105027,8,a,O
105027,8,nadir,O
105027,8,of,O
105027,8,2.5,O
105027,8,to,O
105027,8,the,O
105027,8,9,O
105027,8,'s,O
105027,8,and,O
105027,8,she,O
105027,8,was,O
105027,8,transitioned,O
105027,8,from,O
105027,8,cefepime,B-Drug
105027,8,",",O
105027,8,vancomycin,B-Drug
105027,8,",",O
105027,8,and,O
105027,8,metronidazole,B-Drug
105027,8,to,O
105027,8,oral,O
105027,8,ciprofloxacin,B-Drug
105027,8,.,O
105027,8,All,O
105027,8,cultures,O
105027,8,remained,O
105027,8,negative,O
105027,8,but,O
105027,8,she,O
105027,8,did,O
105027,8,complete,O
105027,8,a,O
105027,8,fourteen,O
105027,8,day,O
105027,8,course,O
105027,8,of,O
105027,8,antibiotics,B-Drug
105027,8,for,O
105027,8,a,O
105027,8,suspected,O
105027,8,pyelonephritis,B-Reason
105027,8,.,O
105027,8,Vasculitis,O
105027,8,was,O
105027,8,also,O
105027,8,considered,O
105027,8,as,O
105027,8,an,O
105027,8,etiology,O
105027,8,for,O
105027,8,her,O
105027,8,SIRS,O
105027,8,but,O
105027,8,no,O
105027,8,clear,O
105027,8,evidence,O
105027,8,for,O
105027,8,a,O
105027,8,particular,O
105027,8,syndrome,O
105027,8,was,O
105027,8,found,O
105027,8,.,O
105027,8,Her,O
105027,8,blood,O
105027,8,pressures,O
105027,8,stabilized,O
105027,8,and,O
105027,8,she,O
105027,8,was,O
105027,8,completely,O
105027,8,hemodynamically,O
105027,8,stable,O
105027,8,for,O
105027,8,>,O
105027,8,1,O
105027,8,wk,O
105027,8,prior,O
105027,8,to,O
105027,8,discharge,O
105027,8,.,O
105027,8,She,O
105027,8,did,O
105027,8,remain,O
105027,8,febrile,O
105027,8,despite,O
105027,8,negative,O
105027,8,cultures,O
105027,8,",",O
105027,8,which,O
105027,8,was,O
105027,8,thought,O
105027,8,most,O
105027,8,likely,O
105027,8,due,O
105027,8,to,O
105027,8,inflammation,O
105027,8,secondary,O
105027,8,to,O
105027,8,her,O
105027,8,necrotic,O
105027,8,kidney,O
105027,8,.,O
105027,8,Prior,O
105027,8,to,O
105027,8,discharge,O
105027,8,her,O
105027,8,fever,O
105027,8,curve,O
105027,8,had,O
105027,8,been,O
105027,8,trending,O
105027,8,down,O
105027,8,and,O
105027,8,she,O
105027,8,did,O
105027,8,not,O
105027,8,become,O
105027,8,more,O
105027,8,febrile,O
105027,8,after,O
105027,8,antibiotics,O
105027,8,were,O
105027,8,stopped,O
105027,8,.,O
105027,8,Cultures,O
105027,8,similarly,O
105027,8,remained,O
105027,8,negative,O
105027,8,.,O
105027,8,Repeat,O
105027,8,MRI,O
105027,8,of,O
105027,8,kidney,O
105027,8,was,O
105027,8,obtained,O
105027,8,to,O
105027,8,look,O
105027,8,for,O
105027,8,an,O
105027,8,abscess,O
105027,8,or,O
105027,8,closed,O
105027,8,space,O
105027,8,infection,O
105027,8,and,O
105027,8,was,O
105027,8,negative,O
105027,8,.,O
105027,8,2,O
105027,8,),O
105027,8,Left,O
105027,8,renal,O
105027,8,infarcts,O
105027,8,:,O
105027,8,Given,O
105027,8,patient,O
105027,8,'s,O
105027,8,family,O
105027,8,history,O
105027,8,of,O
105027,8,factor,O
105027,8,V,O
105027,8,leiden,O
105027,8,mutation,O
105027,8,there,O
105027,8,was,O
105027,8,some,O
105027,8,concern,O
105027,8,that,O
105027,8,she,O
105027,8,could,O
105027,8,have,O
105027,8,a,O
105027,8,thrombophilia,O
105027,8,predisposing,O
105027,8,her,O
105027,8,to,O
105027,8,clot,O
105027,8,.,O
105027,8,Agitated,O
105027,8,saline,O
105027,8,TTE,O
105027,8,revealed,O
105027,8,a,O
105027,8,PFO,O
105027,8,",",O
105027,8,which,O
105027,8,raised,O
105027,8,concern,O
105027,8,for,O
105027,8,paradoxical,O
105027,8,embolization,O
105027,8,but,O
105027,8,work,O
105027,8,up,O
105027,8,for,O
105027,8,VTE,O
105027,8,was,O
105027,9,unremarkable,O
105027,9,.,O
105027,9,Severe,O
105027,9,pyelonephritis,O
105027,9,could,O
105027,9,also,O
105027,9,cause,O
105027,9,renal,O
105027,9,infarction,O
105027,9,but,O
105027,9,as,O
105027,9,reported,O
105027,9,above,O
105027,9,cultures,O
105027,9,never,O
105027,9,impressively,O
105027,9,reenforced,O
105027,9,a,O
105027,9,pyelonephritis,O
105027,9,.,O
105027,9,Similarly,O
105027,9,septic,O
105027,9,emboli,O
105027,9,were,O
105027,9,thought,O
105027,9,extremely,O
105027,9,unlikely,O
105027,9,given,O
105027,9,persistently,O
105027,9,negative,O
105027,9,blood,O
105027,9,cultures,O
105027,9,.,O
105027,9,Investigation,O
105027,9,for,O
105027,9,factor,O
105027,9,V,O
105027,9,leiden,O
105027,9,mutation,O
105027,9,was,O
105027,9,negative,O
105027,9,and,O
105027,9,no,O
105027,9,clear,O
105027,9,reason,O
105027,9,for,O
105027,9,hypercoagulability,O
105027,9,was,O
105027,9,found,O
105027,9,.,O
105027,9,The,O
105027,9,patient,O
105027,9,was,O
105027,9,nevertheless,O
105027,9,anticoagulated,O
105027,9,as,O
105027,9,the,O
105027,9,benefits,O
105027,9,of,O
105027,9,anticoagulation,B-Reason
105027,9,were,O
105027,9,felt,O
105027,9,to,O
105027,9,outweigh,O
105027,9,the,O
105027,9,risks,O
105027,9,.,O
105027,9,Therefore,O
105027,9,",",O
105027,9,she,O
105027,9,was,O
105027,9,started,O
105027,9,on,O
105027,9,coumadin,B-Drug
105027,9,and,O
105027,9,discharged,O
105027,9,on,O
105027,9,this,O
105027,9,as,O
105027,9,well,O
105027,9,as,O
105027,9,enoxaparin,B-Drug
105027,9,for,O
105027,9,bridge,O
105027,9,as,O
105027,9,she,O
105027,9,was,O
105027,9,not,O
105027,9,yet,O
105027,9,therapeutic,O
105027,9,.,O
105027,9,Renal,O
105027,9,function,O
105027,9,remained,O
105027,9,essentially,O
105027,9,stable,O
105027,9,after,O
105027,9,the,O
105027,9,patient,O
105027,9,was,O
105027,9,hydrated,O
105027,9,on,O
105027,9,her,O
105027,9,day,O
105027,9,of,O
105027,9,presentation,O
105027,9,.,O
105027,9,The,O
105027,9,patient,O
105027,9,will,O
105027,9,follow,O
105027,9,up,O
105027,9,in,O
105027,9,hematology,O
105027,9,for,O
105027,9,further,O
105027,9,hypercoagulability,O
105027,9,work-up,O
105027,9,.,O
105027,9,3,O
105027,9,),O
105027,9,Thrombocytopenia,O
105027,9,:,O
105027,9,The,O
105027,9,patient,O
105027,9,was,O
105027,9,transferred,O
105027,9,partially,O
105027,9,due,O
105027,9,to,O
105027,9,concern,O
105027,9,for,O
105027,9,DIC,O
105027,9,or,O
105027,9,TTP,O
105027,9,due,O
105027,9,to,O
105027,9,her,O
105027,9,thrombocytopenia,O
105027,9,.,O
105027,9,Hematology/Oncology,O
105027,9,was,O
105027,9,consulted,O
105027,9,and,O
105027,9,thought,O
105027,9,low,O
105027,9,platelets,O
105027,9,were,O
105027,9,not,O
105027,9,consistent,O
105027,9,with,O
105027,9,DIC,O
105027,9,or,O
105027,9,TTP,O
105027,9,and,O
105027,9,she,O
105027,9,did,O
105027,9,not,O
105027,9,have,O
105027,9,diagnostic,O
105027,9,numbers,O
105027,9,of,O
105027,9,schistocytes,O
105027,9,or,O
105027,9,a,O
105027,9,low,O
105027,9,fibrinogen,O
105027,9,.,O
105027,9,Most,O
105027,9,likely,O
105027,9,etiology,O
105027,9,of,O
105027,9,her,O
105027,9,thrombocytopenia,O
105027,9,was,O
105027,9,thought,O
105027,9,to,O
105027,9,be,O
105027,9,marrow,O
105027,9,suppression,O
105027,9,secondary,O
105027,9,to,O
105027,9,SIRS/sepsis,O
105027,9,.,O
105027,9,Ultimately,O
105027,9,her,O
105027,9,platelet,O
105027,9,count,O
105027,9,recovered,O
105027,9,and,O
105027,9,was,O
105027,9,normal,O
105027,9,at,O
105027,9,the,O
105027,9,time,O
105027,9,of,O
105027,9,discharge,O
105027,9,.,O
105027,9,She,O
105027,9,did,O
105027,9,receive,O
105027,9,one,O
105027,9,unit,O
105027,9,of,O
105027,9,platelets,O
105027,9,during,O
105027,9,an,O
105027,9,IJ,O
105027,9,placement,O
105027,9,.,O
105027,9,4,O
105027,9,),O
105027,9,Pulmonary,O
105027,9,edema/Pleural,O
105027,9,effusions,O
105027,9,:,O
105027,9,Initial,O
105027,9,CXR,O
105027,9,showed,O
105027,9,pulmonary,O
105027,9,edema,O
105027,9,with,O
105027,9,a,O
105027,9,small,O
105027,9,pleural,O
105027,9,effusion,O
105027,9,.,O
105027,9,A,O
105027,9,BNP,O
105027,9,was,O
105027,9,6587,O
105027,9,.,O
105027,9,An,O
105027,9,echocardiogram,O
105027,9,was,O
105027,9,performed,O
105027,9,with,O
105027,9,concern,O
105027,9,for,O
105027,9,cardiovascular,O
105027,9,compromise,O
105027,9,and,O
105027,9,it,O
105027,9,showed,O
105027,9,a,O
105027,9,normal,O
105027,9,ejection,O
105027,9,fraction,O
105027,9,",",O
105027,9,normal,O
105027,9,wall,O
105027,9,motion,O
105027,9,",",O
105027,9,and,O
105027,9,1+MR,O
105027,9,.,O
105027,9,It,O
105027,9,was,O
105027,9,felt,O
105027,9,the,O
105027,9,patient,O
105027,9,'s,O
105027,9,pulmonary,B-ADE
105027,9,edema,I-ADE
105027,9,and,I-ADE
105027,9,effusions,I-ADE
105027,9,were,O
105027,9,secondary,O
105027,9,to,O
105027,9,fluid,B-Drug
105027,9,resuscitation,O
105027,9,.,O
105027,9,She,O
105027,9,had,O
105027,9,one,O
105027,9,episode,O
105027,9,of,O
105027,9,desaturation,O
105027,9,to,O
105027,9,88,O
105027,9,%,O
105027,9,when,O
105027,9,she,O
105027,9,laid,O
105027,9,flat,O
105027,9,in,O
105027,9,her,O
105027,9,CT,O
105027,9,scan,O
105027,9,.,O
105027,9,She,O
105027,9,intermittently,O
105027,9,required,O
105027,9,2,O
105027,9,Liters,O
105027,9,NC,O
105027,9,for,O
105027,9,comfort,O
105027,9,.,O
105027,9,Her,O
105027,10,difficulty,O
105027,10,breathing,O
105027,10,was,O
105027,10,felt,O
105027,10,to,O
105027,10,be,O
105027,10,due,O
105027,10,to,O
105027,10,her,O
105027,10,abdominal,O
105027,10,pain,O
105027,10,causing,O
105027,10,pain,O
105027,10,upon,O
105027,10,deep,O
105027,10,inspiration,O
105027,10,and,O
105027,10,fluid,O
105027,10,overload,O
105027,10,.,O
105027,10,Her,O
105027,10,pain,O
105027,10,was,O
105027,10,controlled,O
105027,10,and,O
105027,10,patient,O
105027,10,was,O
105027,10,auto-diuresing,O
105027,10,>,O
105027,10,150cc/hr,O
105027,10,upon,O
105027,10,transfer,O
105027,10,to,O
105027,10,the,O
105027,10,floor,O
105027,10,.,O
105027,10,She,O
105027,10,continued,O
105027,10,to,O
105027,10,auto-diurese,O
105027,10,on,O
105027,10,the,O
105027,10,floor,O
105027,10,and,O
105027,10,eventually,O
105027,10,came,O
105027,10,off,O
105027,10,of,O
105027,10,oxygen,O
105027,10,entirely,O
105027,10,.,O
105027,10,Better,O
105027,10,pain,O
105027,10,control,O
105027,10,significantly,O
105027,10,improved,O
105027,10,her,O
105027,10,respiratory,O
105027,10,function,O
105027,10,and,O
105027,10,prior,O
105027,10,to,O
105027,10,discharge,O
105027,10,her,O
105027,10,pulmonary,O
105027,10,exam,O
105027,10,was,O
105027,10,normal,O
105027,10,and,O
105027,10,she,O
105027,10,was,O
105027,10,ambulating,O
105027,10,without,O
105027,10,desaturations,O
105027,10,.,O
105027,10,CT,O
105027,10,showed,O
105027,10,a,O
105027,10,persistent,O
105027,10,",",O
105027,10,loculated,O
105027,10,pleural,O
105027,10,effusion,O
105027,10,",",O
105027,10,and,O
105027,10,given,O
105027,10,persistent,O
105027,10,fevers,O
105027,10,",",O
105027,10,a,O
105027,10,thoracentesis,O
105027,10,was,O
105027,10,attempted,O
105027,10,but,O
105027,10,as,O
105027,10,the,O
105027,10,effusion,O
105027,10,was,O
105027,10,steadily,O
105027,10,decreasing,O
105027,10,in,O
105027,10,size,O
105027,10,interventional,O
105027,10,pulmonology,O
105027,10,and,O
105027,10,interventional,O
105027,10,radiology,O
105027,10,thought,O
105027,10,it,O
105027,10,was,O
105027,10,too,O
105027,10,small,O
105027,10,to,O
105027,10,drain,O
105027,10,safely,O
105027,10,.,O
105027,10,As,O
105027,10,it,O
105027,10,continued,O
105027,10,to,O
105027,10,decrease,O
105027,10,in,O
105027,10,size,O
105027,10,and,O
105027,10,the,O
105027,10,patient,O
105027,10,WBC,O
105027,10,count,O
105027,10,and,O
105027,10,fevers,O
105027,10,were,O
105027,10,down,O
105027,10,trending,O
105027,10,this,O
105027,10,was,O
105027,10,not,O
105027,10,pursued,O
105027,10,further,O
105027,10,.,O
105027,10,5,O
105027,10,),O
105027,10,Abdominal,B-Reason
105027,10,pain,I-Reason
105027,10,:,O
105027,10,This,O
105027,10,was,O
105027,10,initially,O
105027,10,controlled,O
105027,10,with,O
105027,10,morphine,B-Drug
105027,10,and,O
105027,10,morphine,B-Drug
105027,10,SR,I-Drug
105027,10,.,O
105027,10,She,O
105027,10,appeared,O
105027,10,to,O
105027,10,be,O
105027,10,very,O
105027,10,drowsy,B-ADE
105027,10,and,O
105027,10,her,O
105027,10,RR,B-ADE
105027,10,decreased,I-ADE
105027,10,on,O
105027,10,this,O
105027,10,regimen,O
105027,10,",",O
105027,10,so,O
105027,10,the,O
105027,10,ms,B-Drug
105027,10,contin,I-Drug
105027,10,was,O
105027,10,discontinued,O
105027,10,.,O
105027,10,She,O
105027,10,continued,O
105027,10,to,O
105027,10,have,O
105027,10,significant,O
105027,10,pain,B-Reason
105027,10,",",O
105027,10,so,O
105027,10,a,O
105027,10,morphine,B-Drug
105027,10,PCA,O
105027,10,",",O
105027,10,maximum,O
105027,10,dose,O
105027,10,of,O
105027,10,4,O
105027,10,mg/hr,O
105027,10,",",O
105027,10,that,O
105027,10,was,O
105027,10,started,O
105027,10,and,O
105027,10,the,O
105027,10,patient,O
105027,10,'s,O
105027,10,pain,O
105027,10,improved,O
105027,10,significantly,O
105027,10,.,O
105027,10,It,O
105027,10,was,O
105027,10,assessed,O
105027,10,that,O
105027,10,her,O
105027,10,pain,O
105027,10,was,O
105027,10,consistent,O
105027,10,with,O
105027,10,post-embolization,O
105027,10,syndrome,O
105027,10,",",O
105027,10,which,O
105027,10,includes,O
105027,10,fever,O
105027,10,",",O
105027,10,abdominal,O
105027,10,pain,O
105027,10,secondary,O
105027,10,to,O
105027,10,the,O
105027,10,clearance,O
105027,10,process,O
105027,10,of,O
105027,10,necrotic,O
105027,10,tissue,O
105027,10,.,O
105027,10,Eventually,O
105027,10,she,O
105027,10,was,O
105027,10,reestablished,O
105027,10,on,O
105027,10,a,O
105027,10,regimen,O
105027,10,of,O
105027,10,morphine,B-Drug
105027,10,SR,I-Drug
105027,10,",",O
105027,10,morphine,B-Drug
105027,10,IR,I-Drug
105027,10,",",O
105027,10,and,O
105027,10,gabapentin,B-Drug
105027,10,with,O
105027,10,good,O
105027,10,improvement,O
105027,10,in,O
105027,10,her,O
105027,10,pain,B-Reason
105027,10,.,O
105027,10,She,O
105027,10,will,O
105027,10,likely,O
105027,10,need,O
105027,10,these,O
105027,10,for,O
105027,10,the,O
105027,10,next,O
105027,10,few,O
105027,10,months,O
105027,10,as,O
105027,10,her,O
105027,10,body,O
105027,10,clears,O
105027,10,necrotic,O
105027,10,tissue,O
105027,10,from,O
105027,10,her,O
105027,10,kidney,O
105027,10,.,O
105027,10,6,O
105027,10,),O
105027,10,Persistent,O
105027,10,sinus,O
105027,10,tachycardia,O
105027,10,:,O
105027,10,The,O
105027,10,patient,O
105027,10,informs,O
105027,10,us,O
105027,10,that,O
105027,10,she,O
105027,10,has,O
105027,10,exhibited,O
105027,10,fast,O
105027,10,heart,O
105027,10,rates,O
105027,10,for,O
105027,10,years,O
105027,10,.,O
105027,10,The,O
105027,10,patient,O
105027,10,did,O
105027,10,not,O
105027,10,appear,O
105027,10,volume,O
105027,11,down,O
105027,11,as,O
105027,11,her,O
105027,11,CVP,O
105027,11,remained,O
105027,11,high,O
105027,11,.,O
105027,11,It,O
105027,11,was,O
105027,11,felt,O
105027,11,that,O
105027,11,the,O
105027,11,tachycardia,O
105027,11,was,O
105027,11,due,O
105027,11,to,O
105027,11,pain,O
105027,11,",",O
105027,11,fever,O
105027,11,and,O
105027,11,the,O
105027,11,overall,O
105027,11,stress,O
105027,11,response,O
105027,11,of,O
105027,11,sepsis,O
105027,11,.,O
105027,11,The,O
105027,11,tachycardia,O
105027,11,improved,O
105027,11,to,O
105027,11,the,O
105027,11,low,O
105027,11,100s,O
105027,11,after,O
105027,11,the,O
105027,11,administration,O
105027,11,of,O
105027,11,the,O
105027,11,PCA,O
105027,11,and,O
105027,11,remained,O
105027,11,there,O
105027,11,through,O
105027,11,the,O
105027,11,day,O
105027,11,of,O
105027,11,discharge,O
105027,11,.,O
105027,11,7,O
105027,11,),O
105027,11,GERD,B-Reason
105027,11,:,O
105027,11,PPI,B-Drug
105027,11,held,O
105027,11,in,O
105027,11,setting,O
105027,11,of,O
105027,11,decreased,O
105027,11,plts,O
105027,11,.,O
105027,11,Ranitidine,B-Drug
105027,11,[,O
105027,11,**Hospital1,O
105027,11,**,O
105027,11,],O
105027,11,started,O
105027,11,and,O
105027,11,then,O
105027,11,discontinued,O
105027,11,when,O
105027,11,platelet,O
105027,11,count,O
105027,11,recovered,O
105027,11,as,O
105027,11,it,O
105027,11,was,O
105027,11,thought,O
105027,11,this,O
105027,11,was,O
105027,11,no,O
105027,11,longer,O
105027,11,indicated,O
105027,11,.,O
105027,11,The,O
105027,11,patient,O
105027,11,had,O
105027,11,a,O
105027,11,PICC,O
105027,11,for,O
105027,11,IV,O
105027,11,access,O
105027,11,that,O
105027,11,was,O
105027,11,discontinued,O
105027,11,prior,O
105027,11,to,O
105027,11,discharge,O
105027,11,.,O
105027,11,She,O
105027,11,was,O
105027,11,tolerating,O
105027,11,a,O
105027,11,full,O
105027,11,diet,O
105027,11,prior,O
105027,11,to,O
105027,11,discharge,O
105027,11,.,O
105027,11,She,O
105027,11,was,O
105027,11,full,O
105027,11,code,O
105027,11,.,O
105027,11,Medications,O
105027,11,on,O
105027,11,Admission,O
105027,11,:,O
105027,11,Neurotin,B-Drug
105027,11,300,O
105027,11,qam,O
105027,11,",",O
105027,11,1500,O
105027,11,qpm,O
105027,11,Protonix,B-Drug
105027,11,daily,O
105027,11,Discharge,O
105027,11,Medications,O
105027,11,:,O
105027,11,1,O
105027,11,.,O
105027,11,Gabapentin,B-Drug
105027,11,300,O
105027,11,mg,O
105027,11,Capsule,O
105027,11,Sig,O
105027,11,:,O
105027,11,One,O
105027,11,(,O
105027,11,1,O
105027,11,),O
105027,11,Capsule,O
105027,11,PO,O
105027,11,Q12H,O
105027,11,(,O
105027,11,every,O
105027,11,12,O
105027,11,hours,O
105027,11,),O
105027,11,as,O
105027,11,needed,O
105027,11,for,O
105027,11,pain,B-Reason
105027,11,for,O
105027,11,1,O
105027,11,months,O
105027,11,.,O
105027,11,Disp,O
105027,11,:,O
105027,11,*60,O
105027,11,Capsule,O
105027,11,(,O
105027,11,s,O
105027,11,),O
105027,11,*,O
105027,11,Refills,O
105027,11,:,O
105027,11,*0*,O
105027,11,2,O
105027,11,.,O
105027,11,Morphine,B-Drug
105027,11,15,O
105027,11,mg,O
105027,11,Tablet,O
105027,11,Sig,O
105027,11,:,O
105027,11,One,O
105027,11,(,O
105027,11,1,O
105027,11,),O
105027,11,Tablet,O
105027,11,PO,O
105027,11,Q4H,O
105027,11,(,O
105027,11,every,O
105027,11,4,O
105027,11,hours,O
105027,11,),O
105027,11,as,O
105027,11,needed,O
105027,11,for,O
105027,11,pain,B-Reason
105027,11,for,O
105027,11,1,O
105027,11,months,O
105027,11,.,O
105027,11,Disp,O
105027,11,:,O
105027,11,*180,O
105027,11,Tablet,O
105027,11,(,O
105027,11,s,O
105027,11,),O
105027,11,*,O
105027,11,Refills,O
105027,11,:,O
105027,11,*0*,O
105027,11,3,O
105027,11,.,O
105027,11,Morphine,B-Drug
105027,11,30,O
105027,11,mg,O
105027,11,Tablet,O
105027,11,Sustained,O
105027,11,Release,O
105027,11,Sig,O
105027,11,:,O
105027,11,One,O
105027,11,(,O
105027,11,1,O
105027,11,),O
105027,11,Tablet,O
105027,11,Sustained,O
105027,11,Release,O
105027,11,PO,O
105027,11,Q8H,O
105027,11,(,O
105027,11,every,O
105027,11,8,O
105027,11,hours,O
105027,11,),O
105027,11,for,O
105027,11,1,O
105027,11,months,O
105027,11,.,O
105027,11,Disp,O
105027,11,:,O
105027,11,*90,O
105027,11,Tablet,O
105027,11,Sustained,O
105027,11,Release,O
105027,11,(,O
105027,11,s,O
105027,11,),O
105027,11,*,O
105027,11,Refills,O
105027,11,:,O
105027,11,*0*,O
105027,11,4,O
105027,11,.,O
105027,11,Enoxaparin,B-Drug
105027,11,60,O
105027,11,mg/0.6,O
105027,11,mL,O
105027,11,Syringe,O
105027,11,Sig,O
105027,11,:,O
105027,11,One,O
105027,11,(,O
105027,11,1,O
105027,11,),O
105027,11,syringe,O
105027,11,Subcutaneous,O
105027,11,Q12H,O
105027,11,(,O
105027,11,every,O
105027,11,12,O
105027,11,hours,O
105027,11,),O
105027,11,for,O
105027,11,1,O
105027,11,months,O
105027,11,.,O
105027,11,Disp,O
105027,11,:,O
105027,11,*60,O
105027,11,syringe*,O
105027,11,Refills,O
105027,11,:,O
105027,11,*0*,O
105027,11,5,O
105027,11,.,O
105027,11,Acetaminophen,B-Drug
105027,11,650,O
105027,11,mg,O
105027,11,Tablet,O
105027,11,Sig,O
105027,11,:,O
105027,11,One,O
105027,11,(,O
105027,11,1,O
105027,11,),O
105027,11,Tablet,O
105027,11,PO,O
105027,11,every,O
105027,11,six,O
105027,11,(,O
105027,11,6,O
105027,11,),O
105027,11,hours,O
105027,12,as,O
105027,12,needed,O
105027,12,for,O
105027,12,fever,B-Reason
105027,12,or,O
105027,12,pain,B-Reason
105027,12,.,O
105027,12,6,O
105027,12,.,O
105027,12,Docusate,B-Drug
105027,12,Sodium,I-Drug
105027,12,100,O
105027,12,mg,O
105027,12,Capsule,O
105027,12,Sig,O
105027,12,:,O
105027,12,One,O
105027,12,(,O
105027,12,1,O
105027,12,),O
105027,12,Capsule,O
105027,12,PO,O
105027,12,twice,O
105027,12,a,O
105027,12,day,O
105027,12,.,O
105027,12,7,O
105027,12,.,O
105027,12,Senna,B-Drug
105027,12,8.6,O
105027,12,mg,O
105027,12,Tablet,O
105027,12,Sig,O
105027,12,:,O
105027,12,Two,O
105027,12,(,O
105027,12,2,O
105027,12,),O
105027,12,Tablet,O
105027,12,PO,O
105027,12,twice,O
105027,12,a,O
105027,12,day,O
105027,12,as,O
105027,12,needed,O
105027,12,for,O
105027,12,constipation,B-Reason
105027,12,.,O
105027,12,8,O
105027,12,.,O
105027,12,Warfarin,B-Drug
105027,12,2,O
105027,12,mg,O
105027,12,Tablet,O
105027,12,Sig,O
105027,12,:,O
105027,12,Two,O
105027,12,(,O
105027,12,2,O
105027,12,),O
105027,12,Tablet,O
105027,12,PO,O
105027,12,Once,O
105027,12,Daily,O
105027,12,at,O
105027,12,4,O
105027,12,PM,O
105027,12,.,O
105027,12,Disp,O
105027,12,:,O
105027,12,*60,O
105027,12,Tablet,O
105027,12,(,O
105027,12,s,O
105027,12,),O
105027,12,*,O
105027,12,Refills,O
105027,12,:,O
105027,12,*2*,O
105027,12,Discharge,O
105027,12,Disposition,O
105027,12,:,O
105027,12,Home,O
105027,12,Discharge,O
105027,12,Diagnosis,O
105027,12,:,O
105027,12,Renal,O
105027,12,infarctions,O
105027,12,of,O
105027,12,unclear,O
105027,12,significance,O
105027,12,?,O
105027,12,Pyelonephritis,O
105027,12,Patent,O
105027,12,foramen,O
105027,12,ovale,O
105027,12,Pleural,O
105027,12,effusion,O
105027,12,Discharge,O
105027,12,Condition,O
105027,12,:,O
105027,12,stable,O
105027,12,Discharge,O
105027,12,Instructions,O
105027,12,:,O
105027,12,You,O
105027,12,were,O
105027,12,admitted,O
105027,12,to,O
105027,12,the,O
105027,12,hospital,O
105027,12,with,O
105027,12,back,O
105027,12,pain,O
105027,12,and,O
105027,12,were,O
105027,12,found,O
105027,12,to,O
105027,12,have,O
105027,12,had,O
105027,12,injuries,O
105027,12,due,O
105027,12,to,O
105027,12,poor,O
105027,12,blood,O
105027,12,flow,O
105027,12,to,O
105027,12,parts,O
105027,12,of,O
105027,12,your,O
105027,12,kidney,O
105027,12,.,O
105027,12,It,O
105027,12,is,O
105027,12,unclear,O
105027,12,exactly,O
105027,12,why,O
105027,12,this,O
105027,12,occurred,O
105027,12,but,O
105027,12,we,O
105027,12,suspect,O
105027,12,you,O
105027,12,may,O
105027,12,have,O
105027,12,some,O
105027,12,predisposition,O
105027,12,toward,O
105027,12,forming,B-Reason
105027,12,blood,I-Reason
105027,12,clots,I-Reason
105027,12,.,O
105027,12,Therefore,O
105027,12,",",O
105027,12,you,O
105027,12,have,O
105027,12,been,O
105027,12,started,O
105027,12,on,O
105027,12,blood,O
105027,12,thinners,O
105027,12,to,O
105027,12,prevent,O
105027,12,futher,O
105027,12,such,O
105027,12,events,O
105027,12,.,O
105027,12,You,O
105027,12,have,O
105027,12,been,O
105027,12,started,O
105027,12,on,O
105027,12,coumadin,B-Drug
105027,12,as,O
105027,12,a,O
105027,12,long,B-Reason
105027,12,term,I-Reason
105027,12,blood,I-Reason
105027,12,thinner,I-Reason
105027,12,",",O
105027,12,you,O
105027,12,are,O
105027,12,being,O
105027,12,discharged,O
105027,12,on,O
105027,12,enoxaparin,B-Drug
105027,12,",",O
105027,12,a,O
105027,12,blood,B-Reason
105027,12,thinner,I-Reason
105027,12,",",O
105027,12,while,O
105027,12,we,O
105027,12,await,O
105027,12,your,O
105027,12,coumadin,B-Drug
105027,12,level,O
105027,12,to,O
105027,12,be,O
105027,12,therapeutic,O
105027,12,.,O
105027,12,You,O
105027,12,will,O
105027,12,need,O
105027,12,to,O
105027,12,see,O
105027,12,a,O
105027,12,hematologist,O
105027,12,as,O
105027,12,an,O
105027,12,outpatient,O
105027,12,to,O
105027,12,complete,O
105027,12,your,O
105027,12,clotting,O
105027,12,disorder,O
105027,12,workup,O
105027,12,.,O
105027,12,You,O
105027,12,had,O
105027,12,fevers,O
105027,12,in,O
105027,12,the,O
105027,12,hospital,O
105027,12,.,O
105027,12,Because,O
105027,12,of,O
105027,12,the,O
105027,12,imaging,O
105027,12,findings,O
105027,12,in,O
105027,12,your,O
105027,12,kidney,O
105027,12,we,O
105027,12,could,O
105027,12,not,O
105027,12,rule,O
105027,12,out,O
105027,12,a,O
105027,12,kidney,O
105027,12,infection,O
105027,12,.,O
105027,12,Therefore,O
105027,12,",",O
105027,12,you,O
105027,12,received,O
105027,12,14,O
105027,12,days,O
105027,12,of,O
105027,12,therapy,O
105027,12,for,O
105027,12,a,O
105027,12,presumed,O
105027,12,kidney,O
105027,12,infection,O
105027,12,.,O
105027,12,You,O
105027,12,completed,O
105027,12,this,O
105027,12,prior,O
105027,12,to,O
105027,12,discharge,O
105027,12,.,O
105027,12,Your,O
105027,12,continued,O
105027,12,fevers,O
105027,12,and,O
105027,12,pain,O
105027,12,are,O
105027,12,likely,O
105027,12,due,O
105027,12,to,O
105027,12,an,O
105027,12,inflammatory,O
105027,12,reaction,O
105027,12,as,O
105027,12,your,O
105027,12,body,O
105027,12,breaks,O
105027,12,down,O
105027,12,the,O
105027,12,portions,O
105027,12,of,O
105027,12,kidney,O
105027,12,tissue,O
105027,12,that,O
105027,12,died,O
105027,12,.,O
105027,12,You,O
105027,12,can,O
105027,12,take,O
105027,12,acetaminophen,B-Drug
105027,12,for,O
105027,12,these,O
105027,12,fevers,B-Reason
105027,12,as,O
105027,12,needed,O
105027,12,.,O
105027,12,Unfortunately,O
105027,12,",",O
105027,13,this,O
105027,13,inflammatory,O
105027,13,reaction,O
105027,13,also,O
105027,13,causes,O
105027,13,pain,B-Reason
105027,13,",",O
105027,13,which,O
105027,13,we,O
105027,13,have,O
105027,13,treated,O
105027,13,with,O
105027,13,multiple,O
105027,13,pain,B-Drug
105027,13,medicines,I-Drug
105027,13,.,O
105027,13,You,O
105027,13,will,O
105027,13,need,O
105027,13,follow,O
105027,13,up,O
105027,13,with,O
105027,13,a,O
105027,13,primary,O
105027,13,care,O
105027,13,provider,O
105027,13,and,O
105027,13,coumadin,B-Drug
105027,13,clinic,O
105027,13,to,O
105027,13,follow,O
105027,13,how,O
105027,13,thin,O
105027,13,your,O
105027,13,blood,O
105027,13,is,O
105027,13,.,O
105027,13,You,O
105027,13,will,O
105027,13,also,O
105027,13,need,O
105027,13,follow,O
105027,13,up,O
105027,13,with,O
105027,13,a,O
105027,13,kidney,O
105027,13,doctor,O
105027,13,to,O
105027,13,follow,O
105027,13,your,O
105027,13,kidney,O
105027,13,function,O
105027,13,",",O
105027,13,a,O
105027,13,hematologist,O
105027,13,to,O
105027,13,assess,O
105027,13,you,O
105027,13,for,O
105027,13,a,O
105027,13,predisposition,O
105027,13,to,O
105027,13,clotting,O
105027,13,and,O
105027,13,help,O
105027,13,manage,O
105027,13,this,O
105027,13,",",O
105027,13,and,O
105027,13,a,O
105027,13,rheumatologist,O
105027,13,as,O
105027,13,some,O
105027,13,of,O
105027,13,your,O
105027,13,tests,O
105027,13,suggest,O
105027,13,a,O
105027,13,possible,O
105027,13,autoimmune,O
105027,13,disorder,O
105027,13,.,O
105027,13,We,O
105027,13,have,O
105027,13,scheduled,O
105027,13,these,O
105027,13,appointments,O
105027,13,for,O
105027,13,you,O
105027,13,.,O
105027,13,Your,O
105027,13,medications,O
105027,13,have,O
105027,13,been,O
105027,13,changed,O
105027,13,.,O
105027,13,You,O
105027,13,have,O
105027,13,been,O
105027,13,started,O
105027,13,on,O
105027,13,coumadin,B-Drug
105027,13,",",O
105027,13,a,O
105027,13,blood,B-Reason
105027,13,thinner,I-Reason
105027,13,",",O
105027,13,that,O
105027,13,you,O
105027,13,will,O
105027,13,need,O
105027,13,to,O
105027,13,take,O
105027,13,until,O
105027,13,your,O
105027,13,are,O
105027,13,told,O
105027,13,to,O
105027,13,stop,O
105027,13,by,O
105027,13,a,O
105027,13,doctor,O
105027,13,.,O
105027,13,Your,O
105027,13,blood,O
105027,13,has,O
105027,13,not,O
105027,13,yet,O
105027,13,been,O
105027,13,thinned,O
105027,13,enough,O
105027,13,by,O
105027,13,coumadin,B-Drug
105027,13,so,O
105027,13,you,O
105027,13,are,O
105027,13,also,O
105027,13,being,O
105027,13,discharged,O
105027,13,on,O
105027,13,ENOXAPARIN,B-Drug
105027,13,(,O
105027,13,LOVENOX,B-Drug
105027,13,),O
105027,13,",",O
105027,13,which,O
105027,13,will,O
105027,13,keep,O
105027,13,your,O
105027,13,blood,O
105027,13,thin,O
105027,13,until,O
105027,13,your,O
105027,13,coumadin,B-Drug
105027,13,levels,O
105027,13,are,O
105027,13,adequate,O
105027,13,.,O
105027,13,When,O
105027,13,your,O
105027,13,coumadin,B-Drug
105027,13,levels,O
105027,13,are,O
105027,13,adequate,O
105027,13,for,O
105027,13,24,O
105027,13,hours,O
105027,13,you,O
105027,13,can,O
105027,13,stop,O
105027,13,the,O
105027,13,enoxaparin,B-Drug
105027,13,.,O
105027,13,You,O
105027,13,have,O
105027,13,also,O
105027,13,been,O
105027,13,started,O
105027,13,on,O
105027,13,MORPHINE,B-Drug
105027,13,sustained,O
105027,13,release,O
105027,13,and,O
105027,13,immediate,O
105027,13,release,O
105027,13,for,O
105027,13,pain,B-Reason
105027,13,.,O
105027,13,You,O
105027,13,should,O
105027,13,not,O
105027,13,drive,O
105027,13,while,O
105027,13,using,O
105027,13,these,O
105027,13,medications,O
105027,13,as,O
105027,13,they,O
105027,13,can,O
105027,13,make,O
105027,13,you,O
105027,13,sleepy,B-ADE
105027,13,.,O
105027,13,You,O
105027,13,were,O
105027,13,also,O
105027,13,started,O
105027,13,on,O
105027,13,GABAPENTIN,B-Drug
105027,13,(,O
105027,13,NEURONTIN,B-Drug
105027,13,),O
105027,13,to,O
105027,13,help,O
105027,13,manage,O
105027,13,your,O
105027,13,pain,B-Reason
105027,13,.,O
105027,13,Please,O
105027,13,seek,O
105027,13,immediate,O
105027,13,medical,O
105027,13,attention,O
105027,13,if,O
105027,13,you,O
105027,13,experience,O
105027,13,chest,O
105027,13,pain,O
105027,13,",",O
105027,13,shortness,O
105027,13,of,O
105027,13,breath,O
105027,13,",",O
105027,13,abdominal,O
105027,13,pain,O
105027,13,",",O
105027,13,or,O
105027,13,any,O
105027,13,change,O
105027,13,from,O
105027,13,your,O
105027,13,baseline,O
105027,13,health,O
105027,13,status,O
105027,13,Followup,O
105027,13,Instructions,O
105027,13,:,O
105027,13,MD,O
105027,13,:,O
105027,13,[,O
105027,13,**First,O
105027,13,Name8,O
105027,13,(,O
105027,13,NamePattern2,O
105027,13,),O
105027,13,**,O
105027,13,],O
105027,13,[,O
105027,13,**Last,O
105027,13,Name,O
105027,13,(,O
105027,13,NamePattern1,O
105027,13,),O
105027,13,**,O
105027,13,],O
105027,13,",",O
105027,13,MD,O
105027,13,Specialty,O
105027,13,:,O
105027,13,PCP,O
105027,13,Date,O
105027,13,and,O
105027,13,time,O
105027,13,:,O
105027,13,Friday,O
105027,13,",",O
105027,13,[,O
105027,13,**2125-10-12**,O
105027,13,],O
105027,13,at,O
105027,13,1:45,O
105027,13,pm,O
105027,13,Location,O
105027,13,:,O
105027,13,[,O
105027,13,**Location,O
105027,13,(,O
105027,13,un,O
105027,13,),O
105027,13,**,O
105027,13,],O
105027,13,",",O
105027,13,[,O
105027,13,**Hospital,O
105027,13,Ward,O
105027,13,Name,O
105027,13,23**,O
105027,13,],O
105027,13,Bldg,O
105027,13,",",O
105027,14,[,O
105027,14,**Location,O
105027,14,(,O
105027,14,un,O
105027,14,),O
105027,14,**,O
105027,14,],O
105027,14,Phone,O
105027,14,number,O
105027,14,:,O
105027,14,[,O
105027,14,**Telephone/Fax,O
105027,14,(,O
105027,14,1,O
105027,14,),O
105027,14,250**,O
105027,14,],O
105027,14,MD,O
105027,14,:,O
105027,14,[,O
105027,14,**First,O
105027,14,Name4,O
105027,14,(,O
105027,14,NamePattern1,O
105027,14,),O
105027,14,**,O
105027,14,],O
105027,14,[,O
105027,14,**Last,O
105027,14,Name,O
105027,14,(,O
105027,14,NamePattern1,O
105027,14,),O
105027,14,1366**,O
105027,14,],O
105027,14,Specialty,O
105027,14,:,O
105027,14,Nephrology,O
105027,14,Date,O
105027,14,and,O
105027,14,time,O
105027,14,:,O
105027,14,Wednesday,O
105027,14,",",O
105027,14,[,O
105027,14,**2128-11-7**,O
105027,14,],O
105027,14,:00,O
105027,14,Location,O
105027,14,:,O
105027,14,[,O
105027,14,**Location,O
105027,14,(,O
105027,14,un,O
105027,14,),O
105027,14,**,O
105027,14,],O
105027,14,",",O
105027,14,[,O
105027,14,**Hospital,O
105027,14,Ward,O
105027,14,Name,O
105027,14,23**,O
105027,14,],O
105027,14,Bldg,O
105027,14,",",O
105027,14,[,O
105027,14,**Location,O
105027,14,(,O
105027,14,un,O
105027,14,),O
105027,14,436**,O
105027,14,],O
105027,14,Phone,O
105027,14,number,O
105027,14,:,O
105027,14,[,O
105027,14,**Telephone/Fax,O
105027,14,(,O
105027,14,1,O
105027,14,),O
105027,14,721**,O
105027,14,],O
105027,14,MD,O
105027,14,:,O
105027,14,[,O
105027,14,**First,O
105027,14,Name8,O
105027,14,(,O
105027,14,NamePattern2,O
105027,14,),O
105027,14,**,O
105027,14,],O
105027,14,[,O
105027,14,**Last,O
105027,14,Name,O
105027,14,(,O
105027,14,NamePattern1,O
105027,14,),O
105027,14,6944**,O
105027,14,],O
105027,14,Specialty,O
105027,14,:,O
105027,14,Hematology,O
105027,14,Date,O
105027,14,and,O
105027,14,time,O
105027,14,:,O
105027,14,Wednesday,O
105027,14,",",O
105027,14,[,O
105027,14,**Month,O
105027,14,(,O
105027,14,only,O
105027,14,),O
105027,14,1096**,O
105027,14,],O
105027,14,Location,O
105027,14,:,O
105027,14,[,O
105027,14,**Location,O
105027,14,(,O
105027,14,un,O
105027,14,),O
105027,14,**,O
105027,14,],O
105027,14,",",O
105027,14,[,O
105027,14,**Hospital,O
105027,14,Ward,O
105027,14,Name,O
105027,14,23**,O
105027,14,],O
105027,14,Bldg,O
105027,14,",",O
105027,14,[,O
105027,14,**Location,O
105027,14,(,O
105027,14,un,O
105027,14,),O
105027,14,436**,O
105027,14,],O
105027,14,Phone,O
105027,14,number,O
105027,14,:,O
105027,14,[,O
105027,14,**Telephone/Fax,O
105027,14,(,O
105027,14,1,O
105027,14,),O
105027,14,68451**,O
105027,14,],O
